Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06319911 · ClinicalTrials.gov registry record

AETOS Shoulder System

A clinical trial of Shoulder Osteoarthritis and Shoulder Arthritis, sponsored by Smith & Nephew.

Recruiting
Registry status
220
Enrollment target
5
Study locations

NCT06319911 is a study of Shoulder Osteoarthritis and Shoulder Arthritis that is actively recruiting participants, run by Smith & Nephew. The registered enrollment target is 220 participants, above the 181-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (22% higher). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06319911, a study of Shoulder Osteoarthritis and Shoulder Arthritis, is actively recruiting participants, sponsored by Smith & Nephew.

RECRUITING
Registry status
220 participants
Enrollment target
5
Study locations

Study Summary

The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization

Interventions

  • DEVICE AETOS

Study Locations (5)

California

  • California Pacific Orthopedics - San Francisco

Colorado

  • Western Orthopaedics - Denver

Georgia

  • Hughston Foundation - Columbus

Oregon

  • Center for Orthopedics and Neurosurgical Care - Bend

Pennsylvania

  • Rothman Institute - Philadelphia

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2024-03-05
Est. Completion 2030-08-30

Sponsor

Smith & Nephew

72 total trials

What the Registry Record Tells You About NCT06319911

The ClinicalTrials.gov registry entry for NCT06319911 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 181-participant average among 9 other Shoulder Osteoarthritis trials with a reported enrollment target (22% higher). The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Shoulder Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which AETOS is the first listed.

NCT06319911 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Georgia.

Frequently Asked Questions

What is clinical trial NCT06319911 about?

NCT06319911 is a clinical study titled "AETOS Shoulder System". The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study ...

What is the current status of trial NCT06319911?

This trial is currently recruiting. The enrollment target is 220 participants. The study started on 2024-03-05. Estimated completion is 2030-08-30.

What conditions does trial NCT06319911 study?

This clinical trial studies the following conditions: Shoulder Osteoarthritis, Shoulder Arthritis.

What interventions are being tested in trial NCT06319911?

The interventions under investigation include: AETOS (DEVICE).

Who is sponsoring clinical trial NCT06319911?

This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06319911 being conducted?

This trial has 5 study locations across California, Colorado, Georgia, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.